Senestech Incorporated (NASDAQ:SNES) Shorted Shares Decreased By 32.6%

January 6, 2018 - By Darrin Black

 Senestech Incorporated (NASDAQ:SNES) Shorted Shares Decreased By 32.6%

The stock of Senestech Incorporated (NASDAQ:SNES) registered a decrease of 32.6% in short interest. SNES’s total short interest was 272,500 shares in January as published by FINRA. Its down 32.6% from 404,300 shares, reported previously. With 681,400 shares average volume, it will take short sellers 0 days to cover their SNES’s short positions. The short interest to Senestech Incorporated’s float is 3.76%.

The stock decreased 0.76% or $0.0056 during the last trading session, reaching $0.7344. About 150,295 shares traded. SenesTech, Inc. (NASDAQ:SNES) has 0.00% since January 6, 2017 and is . It has underperformed by 16.70% the S&P500.

SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. The company has market cap of $11.60 million. The firm focuses on commercializing ContraPest, a fertility control product for use in controlling rat populations. It currently has negative earnings. It is also developing a pipeline of fertility control and animal health products, including plant fertility control, feral animal fertility control, non-surgical spay and neutering, boar taint, and animal cancer treatment.

More notable recent SenesTech, Inc. (NASDAQ:SNES) news were published by: which released: “SenesTech Expands Research and Development with the Hiring of Dr. Dana Skarra” on January 11, 2017, also with their article: “SenesTech, Inc. (SNES) Signs Pact with Target Specialty Products for …” published on November 08, 2017, published: “SenesTech, Inc. (SNES) Prices Offering of Common Stock and Warrants” on November 17, 2017. More interesting news about SenesTech, Inc. (NASDAQ:SNES) were released by: and their article: “SenesTech to Exhibit at PestWorld 2017 in Baltimore” published on October 19, 2017 as well as‘s news article titled: “SenesTech Inc.” with publication date: September 21, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.